Direct Effects of Caffeine on Osteoblastic Cells Metabolism: the Possible Causal Effect of Caffeine on the Formation of Osteoporosis

Overview

Journal J Orthop Surg Res

Publisher Biomed Central

Specialty Orthopedics

Date 2006 Dec 8

PMID 17150127

Citations 26

Authors

Yang-Hwei Tsuang

Jui-Sheng Sun

Li-Ting Chen

Samuel Chung-Kai Sun

San-Chi Chen

Affiliations

Soon will be listed here.

Abstract

Background: Caffeine consumption has been reported to decrease bone mineral density (BMD), increase the risk of hip fracture, and negatively influence calcium retention. In this study, we investigated the influence of caffeine on the osteoblasts behaviour.

Method: Osteoblasts derived from newborn Wistar-rat calvaria was used in this study. The effects of various concentrations of caffeine on bone cell activities were evaluated by using MTT assay. Alkaline phosphatase (ALP) staining, von Kossa staining and biochemical parameters including ALP, lactate dehydrogenase (LDH), prostaglandin E2 (PGE2) and total protein were performed at day 1, 3, and 7. DNA degradation analysis under the caffeine influence was also performed.

Results And Discussion: The results showed that the viability of the osteoblasts, the formation of ALP positive staining colonies and mineralization nodules formation in the osteoblasts cultures decreased significantly in the presence of 10 mM caffeine. The intracellular LDH, ALP and PGE2 content decreased significantly, the LDH and PGE2 secreted into the medium increased significantly. The activation of an irreversible commitment to cell death by caffeine was clearly demonstrated by DNA ladder staining.

Conclusion: In summary, our results suggest that caffeine has potential deleterious effect on the osteoblasts viability, which may enhance the rate of osteoblasts apoptosis.

Citing Articles

Increased Osteoblastic and Osteocytic in Vitro Cell Viability by Yerba Mate (Ilex paraguariensis).

Villarreal L, Sanz N, Fagalde F, DAndrea F, Lombarte M, Rico M J Bone Metab. 2024; 31(2):101-113.

PMID: 38886968 PMC: 11184151. DOI: 10.11005/jbm.2024.31.2.101.

Does Caffeine Affect Dental Implant Stability? A Prospective Cohort Study.

Jafarian M, Tabrizi R, Haghi S, Shafiei S J Dent (Shiraz). 2022; 23(2):102-105.

PMID: 35783490 PMC: 9206705. DOI: 10.30476/DENTJODS.2021.87624.1274.

Effect of Caffeine Injection on Orthodontic Tooth Movement in Rats: An Experimental Study on Rats.

Golshah A, Omidi K, Nikkerdar N, Ghorbani F Int J Dent. 2022; 2022:7204806.

PMID: 35126521 PMC: 8808166. DOI: 10.1155/2022/7204806.

Does Drinking Coffee and Tea Affect Bone Metabolism in Patients with Inflammatory Bowel Diseases?.

Ratajczak A, Szymczak-Tomczak A, Zawada A, Rychter A, Dobrowolska A, Krela-Kazmierczak I Nutrients. 2021; 13(1).

PMID: 33451170 PMC: 7828660. DOI: 10.3390/nu13010216.

Caffeine-Containing, Adaptogenic-Rich Drink Modulates the Effects of Caffeine on Mental Performance and Cognitive Parameters: A Double-Blinded, Placebo-Controlled, Randomized Trial.

Boolani A, Fuller D, Mondal S, Wilkinson T, Darie C, Gumpricht E Nutrients. 2020; 12(7).

PMID: 32610481 PMC: 7399841. DOI: 10.3390/nu12071922.

References

Hall A, Dickson I . The effects of parathyroid hormone on osteoblast-like cells from embryonic chick calvaria. Acta Endocrinol (Copenh). 1985; 108(2):217-23. DOI: 10.1530/acta.0.1080217. View

Packard P, Recker R . Caffeine does not affect the rate of gain in spine bone in young women. Osteoporos Int. 1996; 6(2):149-52. DOI: 10.1007/BF01623939. View

Desimone D, Greene V, Hannon K, Turner R, Bell N . Prostaglandin E2 administered by subcutaneous pellets causes local inflammation and systemic bone loss: a model for inflammation-induced bone disease. J Bone Miner Res. 1993; 8(5):625-34. DOI: 10.1002/jbmr.5650080514. View

Heaney R . Effects of caffeine on bone and the calcium economy. Food Chem Toxicol. 2002; 40(9):1263-70. DOI: 10.1016/s0278-6915(02)00094-7. View

Fuller K, Chambers T . Effect of arachidonic acid metabolites on bone resorption by isolated rat osteoclasts. J Bone Miner Res. 1989; 4(2):209-15. DOI: 10.1002/jbmr.5650040212. View

Ohta M, Cheuk G, Yazdani M, Saltzman M, Nakamoto T . Combined effects of caffeine and prostaglandin E2 on the proliferation of osteoblast-like cells (UMR106-01). J Periodontol. 1999; 70(3):283-8. DOI: 10.1902/jop.1999.70.3.283. View

Coelho M, Fernandes M . Human bone cell cultures in biocompatibility testing. Part II: effect of ascorbic acid, beta-glycerophosphate and dexamethasone on osteoblastic differentiation. Biomaterials. 2000; 21(11):1095-102. DOI: 10.1016/s0142-9612(99)00192-1. View

Smith S, Swain J, Brown E, Wyshak G, Albright T, Ravnikar V . A preliminary report of the short-term effect of carbonated beverage consumption on calcium metabolism in normal women. Arch Intern Med. 1989; 149(11):2517-9. View

Lerner U, Ransjo M, Ljunggren O . Prostaglandin E2 causes a transient inhibition of mineral mobilization, matrix degradation, and lysosomal enzyme release from mouse calvarial bones in vitro. Calcif Tissue Int. 1987; 40(6):323-31. DOI: 10.1007/BF02556694. View

10.

Quinn J, Sabokbar A, Denne M, De Vernejoul M, Mcgee J, Athanasou N . Inhibitory and stimulatory effects of prostaglandins on osteoclast differentiation. Calcif Tissue Int. 1997; 60(1):63-70. DOI: 10.1007/s002239900187. View

11.

Rapuri P, Gallagher J, Kinyamu H, Ryschon K . Caffeine intake increases the rate of bone loss in elderly women and interacts with vitamin D receptor genotypes. Am J Clin Nutr. 2001; 74(5):694-700. DOI: 10.1093/ajcn/74.5.694. View

12.

Hannan M, Felson D, Dawson-Hughes B, Tucker K, Cupples L, Wilson P . Risk factors for longitudinal bone loss in elderly men and women: the Framingham Osteoporosis Study. J Bone Miner Res. 2000; 15(4):710-20. DOI: 10.1359/jbmr.2000.15.4.710. View

13.

Hoeberichts F, Woltering E . Multiple mediators of plant programmed cell death: interplay of conserved cell death mechanisms and plant-specific regulators. Bioessays. 2003; 25(1):47-57. DOI: 10.1002/bies.10175. View

14.

Mosmann T . Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983; 65(1-2):55-63. DOI: 10.1016/0022-1759(83)90303-4. View

15.

Reid I, Ames R, Evans M, Sharpe S, Gamble G . Determinants of the rate of bone loss in normal postmenopausal women. J Clin Endocrinol Metab. 1994; 79(4):950-4. DOI: 10.1210/jcem.79.4.7962303. View

16.

Doherty M, Schlag G, Schwarz N, Mollan R, Nolan P, Wilson D . Biocompatibility of xenogeneic bone, commercially available coral, a bioceramic and tissue sealant for human osteoblasts. Biomaterials. 1994; 15(8):601-8. DOI: 10.1016/0142-9612(94)90210-0. View

17.

Stein G, Lian J, Stein J, van Wijnen A, Montecino M . Transcriptional control of osteoblast growth and differentiation. Physiol Rev. 1996; 76(2):593-629. DOI: 10.1152/physrev.1996.76.2.593. View

18.

Harris S, Enger R, Riggs B, Spelsberg T . Development and characterization of a conditionally immortalized human fetal osteoblastic cell line. J Bone Miner Res. 1995; 10(2):178-86. DOI: 10.1002/jbmr.5650100203. View

19.

Saraste A, Pulkki K . Morphologic and biochemical hallmarks of apoptosis. Cardiovasc Res. 2000; 45(3):528-37. DOI: 10.1016/s0008-6363(99)00384-3. View

20.

Johnell O, Gullberg B, Kanis J, Allander E, Elffors L, Dequeker J . Risk factors for hip fracture in European women: the MEDOS Study. Mediterranean Osteoporosis Study. J Bone Miner Res. 1995; 10(11):1802-15. DOI: 10.1002/jbmr.5650101125. View